In the latest trading session,, 0.37 million Protalix BioTherapeutics Inc (AMEX:PLX) shares changed hands as the company’s beta touched 0.08. With the company’s most recent per share price at $2.17 changed hands at -$0.11 or -4.61% at last look, the market valuation stands at $169.72M. PLX’s current price is a discount, trading about -27.19% off its 52-week high of $2.76. The share price had its 52-week low at $0.82, which suggests the last value was 62.21% up since then. When we look at Protalix BioTherapeutics Inc’s average trading volume, we note the 10-day average is 0.59 million shares, with the 3-month average coming to 669.97K.
Protalix BioTherapeutics Inc (AMEX:PLX) trade information
Instantly PLX was in red as seen in intraday trades today. With action -16.02%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 15.69%, with the 5-day performance at -16.02% in the red. However, in the 30-day time frame, Protalix BioTherapeutics Inc (AMEX:PLX) is -3.76% down. Looking at the short shares, we see there were 0.65 million shares sold at short interest cover period of 0.99 days.
Protalix BioTherapeutics Inc (AMEX:PLX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 13.70% of Protalix BioTherapeutics Inc shares while 6.03% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 6.98%. There are 6.03% institutions holding the Protalix BioTherapeutics Inc stock share, with MILLENNIUM MANAGEMENT LLC the top institutional holder. As of 2024-06-30, the company held 1.1106% of the shares, roughly 0.81 million PLX shares worth $0.95 million.
RENAISSANCE TECHNOLOGIES LLC holds the second largest percentage of outstanding shares, with 1.1016% or 0.8 million shares worth $0.94 million as of 2024-06-30.
Among Mutual Funds, the top two as of Feb 28, 2025 were Unified Series Trust-AUER GROWTH FUND and Bridgeway Funds, Inc.-Ultra-Small Company Market Fund . With 200.0 shares estimated at $0.43 million under it, the former controlled 0.26% of total outstanding shares. On the other hand, Bridgeway Funds, Inc.-Ultra-Small Company Market Fund held about 0.23% of the shares, roughly 180.0 shares worth around $0.39 million.
